2016
DOI: 10.1093/ehjqcco/qcw001
|View full text |Cite
|
Sign up to set email alerts
|

Functional performance and quality of life in high-risk comorbid patients undergoing transcatheter aortic valve implantation for symptomatic aortic valve stenosis

Abstract: In high-risk comorbid patients with symptomatic AS, TAVI results in a significant but temporary improvement of functional performance when assessed with objective measures of 6MWD but not of EQ-5D. Moreover, TAVI has a significant and sustained impact on subjective well-being and exercise capacity assessed with the EQ-VAS and NYHA score.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
9
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(10 citation statements)
references
References 36 publications
1
9
0
Order By: Relevance
“…The results of the present study concur with those in the literature on overall worsening of functional status (Hiltrop et al, 2016;Miguelena-Hycka et al, 2019;Prada-Arrondo, 2021). In previous studies, functional outcomes were worse in patients with a diagnosis of cognitive decline (Bendikaite and Vimantaite, 2020).…”
Section: Discussionsupporting
confidence: 93%
“…The results of the present study concur with those in the literature on overall worsening of functional status (Hiltrop et al, 2016;Miguelena-Hycka et al, 2019;Prada-Arrondo, 2021). In previous studies, functional outcomes were worse in patients with a diagnosis of cognitive decline (Bendikaite and Vimantaite, 2020).…”
Section: Discussionsupporting
confidence: 93%
“…However, 6MWT increased significantly after 1 year in a cohort randomized to TAVI compared to no change in those randomized to medical therapy 13 , arguing against a Hawthorne effect. A second explanation for our findings is that quality of life questionnaires and 6MWT 4 produce an abundance of motivation in the hospital setting that does not correspond to daily life. In this case the findings on standard tests (6MWT, QoL questionnaires) would appear improved, whereas parameters on the health watch would remain unchanged.…”
Section: Discussionmentioning
confidence: 90%
“…1, 2 Not all TAVI patients benefit from improved physical activity as assessed by a 6-minute walking test (6MWT) or quality of life (QoL) questionnaire. 3, 4 However, these tests could be influenced by other factors and comorbidities like peripheral vascular disease for the 6MWT or depression for the QoL questionnaire. Another concern with such tools is that they merely provide a snapshot of a patient’s life, and might change under different circumstances.…”
Section: Introductionmentioning
confidence: 99%
“…They found that CCI scores at baseline did not appear to differ between patients who died and patients who survived at 2 years of follow-up after TAVR. [16] The difference in the number and characteristics of participants may be the main reason for the different results. Their patients had significantly lower comorbidities than our study population, including patients with both transfemoral and transapical approaches, whereas our study did not include patients with transapical approaches.…”
Section: Discussionmentioning
confidence: 99%
“…[15] However, Hiltrop et al found no difference in CCI scores between survivors and deceased populations at 2 years follow-up post-TAVR. [16] Another study also found that the CCI score was not independently associated with a higher risk of 30-day death but can be useful in addition to Logistic Euro Score (LES) and Society of Thoracic Surgeons (STS) risk models in informing decision making on the selection of patients for TAVR. [17] Furthermore, it is unknown whether Age-CCI is associated with 1-year readmission rate in patients who underwent TAVR.…”
Section: Introductionmentioning
confidence: 99%